50 employees
Edgemont Pharmaceuticals focuses on the field of neuroscience and develops novel drug formulations and therapies to improve patient care.
2006
$5M
from 1 investors over 1 rounds
Edgemont Pharmaceuticals, LLC raised $5M on May 1, 2015
Investors: Oxford Finance LLC